Narayana Hrudayalaya Limited (NSE:NH) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Nishant Singh -- Head of Investor Relations Emmanuel Rupert -- Managing
Narayana Hrudayalaya Limited (NH) Q3 FY23 Earnings Concall Transcript
Categories
Health Care
Krishna Institute of Medical Sciences Limited (KIMS) Q3 FY23 Earnings Concall Transcript
Krishna Institute of Medical Sciences Limited (NSE:KIMS) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Bhaskar Rao Bollineni -- Founder and Managing
NATCO Pharma Limited (NATCOPHARM) Q3 FY23 Earnings Concall Transcript
NATCO Pharma Limited (NSE:NATCOPHARM) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Rajesh Chebiyam -- Executive Vice President of Crop Health Science
Aurobindo Pharma Limited (AUROPHARMA) Q3 FY23 Earnings Concall Transcript
Aurobindo Pharma Limited (NSE:AUROPHARMA) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Deepti Thakur -- Investor Relations Santhanam Subramanian -- Chief Financial Officer Satakarni
Healthcare Global Enterprises Ltd (HCG) Q3 FY23 Earnings Concall Transcript
Healthcare Global Enterprises Ltd (NSE:HCG) Q3 FY23 Earnings Concall dated Feb. 09, 2023. Corporate Participants: BS Ajai Kumar -- Executive Chairman Raj Gore -- Whole-time Director
Windlas Biotech Limited (WINDLAS) Q3 FY23 Earnings Concall Transcript
Windlas Biotech Limited (NSE:WINDLAS) Q3 FY23 Earnings Concall dated Feb. 09, 2023. Corporate Participants: Hitesh Windlas -- Managing Director Komal Gupta -- Chief Executive Officer and
ABBOTT INDIA LTD Ltd. (NSE: ABBOTTINDIA): Q3 FY23 Results Out; Total Income Rises 10% YoY
Abbott India Limited (NSE:ABBOTTINDIA) is a subsidiary of Abbott Laboratories, a multinational healthcare company. It was established in India in 1944 and
Alkem Laboratories Ltd. (NSE: ALKEM): Q3 FY23 Results Out; Total Income Rises 15% YoY
Alkem Laboratories Ltd.(NSE:ALKEM) is a pharmaceutical company that specializes in developing, manufacturing, and marketing of pharmaceutical and nutraceutical products. The company operates
Zydus lifescience net profit soars by 23% in Q3FY23
Zydus Lifesciences Ltd reported a 23 per cent rise in consolidated net profit at INR 631 crore for the third quarter ended
JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q3 FY23 Earnings Concall Transcript
JB Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Q3 FY23 Earnings Concall dated Feb. 09, 2023. Corporate Participants: Jason D'Souza -- Vice President, Investor Relations Nikhil
Piramal Pharma Ltd (PPLPHARMA) Q3 FY23 Earnings Concall Transcript
Piramal Pharma Ltd (NSE: PPLPHARMA) Q3 FY23 Earnings Concall dated Feb. 09, 2023 Corporate Participants: Gagan Borana -- General Manager, Investor Relations and Sustainability
Lupin Limited Q3FY23; 47% Growth in Profits
Lupin Limited’s revenue in Q3FY23 rose 13% to ₹ 1,97,66,301 lakhs. Consolidated Profit After Tax came at ₹ 8,34,871 lakhs in Q3FY23
MedPlus Health Limited Q3FY23 Earnings
When it comes to the number of stores and revenue, MedPlus Health Services is one of the largest pharmacy retailers in India.
Aurobindo Pharma Limited (NSE: AUROPHARMA): Q3 FY23 Results Out; Total Income Rises 7% YoY
Aurobindo Pharma Limited (NSE: AUROPHARMA) is a pharmaceutical company based in Hyderabad, India. The company was founded in 1986 and has since
Piramal Enterprises Ltd Q3 FY23 Earnings Conference Call Insights
Key highlights from Piramal Enterprises Ltd (PEL) Q3 FY23 Earnings Concall Q&A Highlights: [00:16:30] Abhijit Tibrewal from Motilal Oswal asked about asset
Thyrocare Technologies net profit declines by 43% in the December 2022 quarter
Net profit of Thyrocare Technologies declined by 43.47% to INR 13 crore in the quarter ended December 2022 as against INR 23
Sun Pharmaceutical Q3FY23; 3% Growth in Profits
Sun Pharmaceutical Industries Limited’s revenue in Q3FY23 rose 14% to ₹ 112,410 millions. Consolidated Profit After Tax came at ₹ 21,808 millions
SUVEN PHARMACEUTICALS LTD (SUVEN) Q3 FY23 Earnings Concall Transcript
SUVEN PHARMACEUTICALS LTD (NSE:SUVEN) Q3 FY23 Earnings Concall dated Feb. 07, 2023. Corporate Participants: Rishab Barar -- Investor Relations Venkat Jasti -- Managing Director Venkatraman Sunder -- Vice
Aarti Industries Ltd Q3 FY23 Earnings Conference Call Insights
Key highlights from Aarti Industries Ltd (AARTIIND) Q3 FY23 Earnings Concall Management Update: [00:04:16] AARTIIND said demand for textile products was impacted
Gujarat Themis Biosyn Limited (506879) Q3 FY23 Earnings Concall Transcript
Gujarat Themis Biosyn Limited (NSE:506879) Q3 FY23 Earnings Concall dated Feb. 06, 2023. Corporate Participants: Sachin Patel -- Director Rajneesh Anand -- Consultant Analysts: Saloni Hemnani -- Molecule
MedPlus Health Services Ltd (MEDPLUS) Q3 FY23 Earnings Concall Transcript
MedPlus Health Services Ltd (NSE:MEDPLUS) Q3 FY23 Earnings Concall dated Feb. 06, 2023. Corporate Participants: Prasad Reddy Battinapatla -- Assistant Financial Controller Gangadi Madhukar